FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023173606> ?p ?o ?g. }

• W2023173606 endingPage "1086" @default.
• W2023173606 startingPage "1083" @default.
• W2023173606 abstract "Hypertension is a well-known risk factor for atherosclerosis. However, data on the impact of hypertension in patients with ST elevation myocardial infarction (STEMI) are inconsistent and mainly related to studies performed in the thrombolytic era, with very few data on patients undergoing primary angioplasty. The aim of the present study was to evaluate the impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with STEMI undergoing primary percutaneous coronary intervention. Our population is represented by 1,662 patients undergoing primary angioplasty for STEMI included in the Early Glycoprotein IIb-IIIa inhibitors in Primary angioplasty database. Myocardial perfusion was evaluated by myocardial blush grade and ST segment resolution. Follow-up data were collected within 1 year after primary angioplasty. Hypertension was observed in 700 patients (42.1%). Hypertension was associated with more advanced age (p <0.001), female gender (p <0.001), diabetes (p <0.001), hypercholesterolemia (p <0.001), previous revascularization (p <0.001), anterior myocardial infarction (p = 0.006), longer ischemia time (p = 0.03), more extensive coronary artery disease (p = 0.002), more often treated with abciximab (p <0.001), and less often smokers (p <0.001). Hypertension was associated with impaired postprocedural myocardial blush grade 2 to 3 (68.2% vs 74.2%, p = 0.019) and complete ST segment resolution (51.7% vs 61.1%, p = 0.001). By a mean follow-up of 206 ± 158 days, 70 patients (4.3%) had died. Hypertension was associated with a greater mortality (6.2% vs 2.9%, hazard ratio 2.31, 95% confidence interval 1.42 to 3.73, p <0.001), confirmed after correction for baseline confounding factors (hazard ratio 1.82, 95% confidence interval 1.03 to 3.22, p <0.001). In conclusion, this study showed that among patients with STEMI undergoing primary angioplasty, hypertension is associated with impaired reperfusion and independently predicts 1-year mortality. Hypertension is a well-known risk factor for atherosclerosis. However, data on the impact of hypertension in patients with ST elevation myocardial infarction (STEMI) are inconsistent and mainly related to studies performed in the thrombolytic era, with very few data on patients undergoing primary angioplasty. The aim of the present study was to evaluate the impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with STEMI undergoing primary percutaneous coronary intervention. Our population is represented by 1,662 patients undergoing primary angioplasty for STEMI included in the Early Glycoprotein IIb-IIIa inhibitors in Primary angioplasty database. Myocardial perfusion was evaluated by myocardial blush grade and ST segment resolution. Follow-up data were collected within 1 year after primary angioplasty. Hypertension was observed in 700 patients (42.1%). Hypertension was associated with more advanced age (p <0.001), female gender (p <0.001), diabetes (p <0.001), hypercholesterolemia (p <0.001), previous revascularization (p <0.001), anterior myocardial infarction (p = 0.006), longer ischemia time (p = 0.03), more extensive coronary artery disease (p = 0.002), more often treated with abciximab (p <0.001), and less often smokers (p <0.001). Hypertension was associated with impaired postprocedural myocardial blush grade 2 to 3 (68.2% vs 74.2%, p = 0.019) and complete ST segment resolution (51.7% vs 61.1%, p = 0.001). By a mean follow-up of 206 ± 158 days, 70 patients (4.3%) had died. Hypertension was associated with a greater mortality (6.2% vs 2.9%, hazard ratio 2.31, 95% confidence interval 1.42 to 3.73, p <0.001), confirmed after correction for baseline confounding factors (hazard ratio 1.82, 95% confidence interval 1.03 to 3.22, p <0.001). In conclusion, this study showed that among patients with STEMI undergoing primary angioplasty, hypertension is associated with impaired reperfusion and independently predicts 1-year mortality." @default.
• W2023173606 created "2016-06-24" @default.
• W2023173606 creator A5007026783 @default.
• W2023173606 creator A5019601885 @default.
• W2023173606 creator A5021517783 @default.
• W2023173606 creator A5026808439 @default.
• W2023173606 creator A5028227968 @default.
• W2023173606 creator A5036197968 @default.
• W2023173606 creator A5037728621 @default.
• W2023173606 creator A5038328891 @default.
• W2023173606 creator A5041712070 @default.
• W2023173606 creator A5057352435 @default.
• W2023173606 creator A5064670948 @default.
• W2023173606 creator A5067049329 @default.
• W2023173606 creator A5075302859 @default.
• W2023173606 creator A5077862111 @default.
• W2023173606 creator A5082920214 @default.
• W2023173606 creator A5085798844 @default.
• W2023173606 creator A5088696580 @default.
• W2023173606 date "2013-10-01" @default.
• W2023173606 modified "2023-10-17" @default.
• W2023173606 title "Impact of Hypertension on Distal Embolization, Myocardial Perfusion, and Mortality in Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty" @default.
• W2023173606 cites W1980080465 @default.
• W2023173606 cites W1989056343 @default.
• W2023173606 cites W1991264910 @default.
• W2023173606 cites W2008977182 @default.
• W2023173606 cites W2021970054 @default.
• W2023173606 cites W2042425502 @default.
• W2023173606 cites W2042474425 @default.
• W2023173606 cites W2057572363 @default.
• W2023173606 cites W2059627219 @default.
• W2023173606 cites W2064195086 @default.
• W2023173606 cites W2065620709 @default.
• W2023173606 cites W2078903829 @default.
• W2023173606 cites W2086343653 @default.
• W2023173606 cites W2093392020 @default.
• W2023173606 cites W2095537806 @default.
• W2023173606 cites W2113954763 @default.
• W2023173606 cites W2115801818 @default.
• W2023173606 cites W2156927593 @default.
• W2023173606 doi "https://doi.org/10.1016/j.amjcard.2013.05.053" @default.
• W2023173606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23910428" @default.
• W2023173606 hasPublicationYear "2013" @default.
• W2023173606 type Work @default.
• W2023173606 sameAs 2023173606 @default.
• W2023173606 citedByCount "12" @default.
• W2023173606 countsByYear W20231736062013 @default.
• W2023173606 countsByYear W20231736062014 @default.
• W2023173606 countsByYear W20231736062015 @default.
• W2023173606 countsByYear W20231736062016 @default.
• W2023173606 countsByYear W20231736062017 @default.
• W2023173606 countsByYear W20231736062018 @default.
• W2023173606 countsByYear W20231736062019 @default.
• W2023173606 countsByYear W20231736062021 @default.
• W2023173606 crossrefType "journal-article" @default.
• W2023173606 hasAuthorship W2023173606A5007026783 @default.
• W2023173606 hasAuthorship W2023173606A5019601885 @default.
• W2023173606 hasAuthorship W2023173606A5021517783 @default.
• W2023173606 hasAuthorship W2023173606A5026808439 @default.
• W2023173606 hasAuthorship W2023173606A5028227968 @default.
• W2023173606 hasAuthorship W2023173606A5036197968 @default.
• W2023173606 hasAuthorship W2023173606A5037728621 @default.
• W2023173606 hasAuthorship W2023173606A5038328891 @default.
• W2023173606 hasAuthorship W2023173606A5041712070 @default.
• W2023173606 hasAuthorship W2023173606A5057352435 @default.
• W2023173606 hasAuthorship W2023173606A5064670948 @default.
• W2023173606 hasAuthorship W2023173606A5067049329 @default.
• W2023173606 hasAuthorship W2023173606A5075302859 @default.
• W2023173606 hasAuthorship W2023173606A5077862111 @default.
• W2023173606 hasAuthorship W2023173606A5082920214 @default.
• W2023173606 hasAuthorship W2023173606A5085798844 @default.
• W2023173606 hasAuthorship W2023173606A5088696580 @default.
• W2023173606 hasConcept C126322002 @default.
• W2023173606 hasConcept C164705383 @default.
• W2023173606 hasConcept C2778213512 @default.
• W2023173606 hasConcept C2779464278 @default.
• W2023173606 hasConcept C2780326628 @default.
• W2023173606 hasConcept C2780400711 @default.
• W2023173606 hasConcept C3020416370 @default.
• W2023173606 hasConcept C500558357 @default.
• W2023173606 hasConcept C71924100 @default.
• W2023173606 hasConceptScore W2023173606C126322002 @default.
• W2023173606 hasConceptScore W2023173606C164705383 @default.
• W2023173606 hasConceptScore W2023173606C2778213512 @default.
• W2023173606 hasConceptScore W2023173606C2779464278 @default.
• W2023173606 hasConceptScore W2023173606C2780326628 @default.
• W2023173606 hasConceptScore W2023173606C2780400711 @default.
• W2023173606 hasConceptScore W2023173606C3020416370 @default.
• W2023173606 hasConceptScore W2023173606C500558357 @default.
• W2023173606 hasConceptScore W2023173606C71924100 @default.
• W2023173606 hasIssue "8" @default.
• W2023173606 hasLocation W20231736061 @default.
• W2023173606 hasLocation W20231736062 @default.
• W2023173606 hasOpenAccess W2023173606 @default.
• W2023173606 hasPrimaryLocation W20231736061 @default.
• W2023173606 hasRelatedWork W2101065585 @default.
• W2023173606 hasRelatedWork W2375584960 @default.
• W2023173606 hasRelatedWork W2399382480 @default.

• next